FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891422085> ?p ?o ?g. }

• W2891422085 endingPage "211" @default.
• W2891422085 startingPage "199" @default.
• W2891422085 abstract "Administration of influenza vaccines via the respiratory tract has potential benefits over conventional parenteral administration, inducing immunity directly at the site of influenza exposure as well as being needle free. In this study, we investigated the suitability of Advax™, a stable particulate polymorph of inulin, also referred to as delta inulin, as a mucosal adjuvant for whole inactivated influenza vaccine (WIV) administered either as a liquid or dry powder formulation. Spray freeze-drying produced Advax-adjuvanted WIV powder particles in a size range (1–5 μm) suitable for inhalation. The physical and biological characteristics of both WIV and Advax remained unaltered both by admixing WIV with Advax and by spray freeze drying. Upon intranasal or pulmonary immunization, both liquid and dry powder formulations containing Advax induced significantly higher systemic, mucosal and cellular immune responses than non-adjuvanted WIV formulations. Furthermore, pulmonary immunization with Advax-adjuvanted WIV led to robust memory B cell responses along with an increase of lung localization factors i.e. CXCR3, CD69, and CD103. A less pronounced but still positive effect of Advax was seen on memory T cell responses. In contrast to animals immunized with WIV alone, all animals pulmonary immunized with a single dose of Advax-adjuvanted WIV were fully protected with no visible clinical symptoms against a lethal dose of influenza virus. These data confirm that Advax is a potent mucosal adjuvant that boosts vaccine-induced humoral and cellular immune responses both in the lung and systemically with major positive effects on B-cell memory and complete protection against live virus. Hence, respiratory tract immunization, particularly via the lungs, with Advax-adjuvanted WIV formulation as a liquid or dry powder is a promising alternative to parenteral influenza vaccination." @default.
• W2891422085 created "2018-09-27" @default.
• W2891422085 creator A5008287871 @default.
• W2891422085 creator A5012996455 @default.
• W2891422085 creator A5013977907 @default.
• W2891422085 creator A5015459346 @default.
• W2891422085 creator A5028635430 @default.
• W2891422085 creator A5035952908 @default.
• W2891422085 creator A5039752389 @default.
• W2891422085 creator A5050320049 @default.
• W2891422085 creator A5079311523 @default.
• W2891422085 date "2018-10-01" @default.
• W2891422085 modified "2023-10-14" @default.
• W2891422085 title "Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge" @default.
• W2891422085 cites W1519480055 @default.
• W2891422085 cites W1573380982 @default.
• W2891422085 cites W1788782297 @default.
• W2891422085 cites W1861790843 @default.
• W2891422085 cites W1929270371 @default.
• W2891422085 cites W1968789597 @default.
• W2891422085 cites W1972455048 @default.
• W2891422085 cites W1974822286 @default.
• W2891422085 cites W1991780615 @default.
• W2891422085 cites W1996779770 @default.
• W2891422085 cites W2002392006 @default.
• W2891422085 cites W2004037102 @default.
• W2891422085 cites W2004313661 @default.
• W2891422085 cites W2004433396 @default.
• W2891422085 cites W2005006106 @default.
• W2891422085 cites W2006760510 @default.
• W2891422085 cites W2009253992 @default.
• W2891422085 cites W2010454855 @default.
• W2891422085 cites W2012858553 @default.
• W2891422085 cites W2015245677 @default.
• W2891422085 cites W2017576872 @default.
• W2891422085 cites W2020895158 @default.
• W2891422085 cites W2026559331 @default.
• W2891422085 cites W2030796658 @default.
• W2891422085 cites W2035269438 @default.
• W2891422085 cites W2037073876 @default.
• W2891422085 cites W2039200386 @default.
• W2891422085 cites W2042592958 @default.
• W2891422085 cites W2043521350 @default.
• W2891422085 cites W2072091568 @default.
• W2891422085 cites W2081589055 @default.
• W2891422085 cites W2083048250 @default.
• W2891422085 cites W2091459248 @default.
• W2891422085 cites W2140205268 @default.
• W2891422085 cites W2142174337 @default.
• W2891422085 cites W2142246084 @default.
• W2891422085 cites W2146957723 @default.
• W2891422085 cites W2150950122 @default.
• W2891422085 cites W2153010224 @default.
• W2891422085 cites W2157995390 @default.
• W2891422085 cites W2159254827 @default.
• W2891422085 cites W2161001526 @default.
• W2891422085 cites W2161989681 @default.
• W2891422085 cites W2258670756 @default.
• W2891422085 cites W2344451831 @default.
• W2891422085 cites W2460836560 @default.
• W2891422085 cites W2474614962 @default.
• W2891422085 cites W2599366988 @default.
• W2891422085 cites W2729597877 @default.
• W2891422085 cites W2738672432 @default.
• W2891422085 cites W2753081290 @default.
• W2891422085 cites W2792964171 @default.
• W2891422085 cites W4249175616 @default.
• W2891422085 doi "https://doi.org/10.1016/j.jconrel.2018.09.006" @default.
• W2891422085 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7111335" @default.
• W2891422085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30218687" @default.
• W2891422085 hasPublicationYear "2018" @default.
• W2891422085 type Work @default.
• W2891422085 sameAs 2891422085 @default.
• W2891422085 citedByCount "40" @default.
• W2891422085 countsByYear W28914220852018 @default.
• W2891422085 countsByYear W28914220852019 @default.
• W2891422085 countsByYear W28914220852020 @default.
• W2891422085 countsByYear W28914220852021 @default.
• W2891422085 countsByYear W28914220852022 @default.
• W2891422085 countsByYear W28914220852023 @default.
• W2891422085 crossrefType "journal-article" @default.
• W2891422085 hasAuthorship W2891422085A5008287871 @default.
• W2891422085 hasAuthorship W2891422085A5012996455 @default.
• W2891422085 hasAuthorship W2891422085A5013977907 @default.
• W2891422085 hasAuthorship W2891422085A5015459346 @default.
• W2891422085 hasAuthorship W2891422085A5028635430 @default.
• W2891422085 hasAuthorship W2891422085A5035952908 @default.
• W2891422085 hasAuthorship W2891422085A5039752389 @default.
• W2891422085 hasAuthorship W2891422085A5050320049 @default.
• W2891422085 hasAuthorship W2891422085A5079311523 @default.
• W2891422085 hasBestOaLocation W28914220851 @default.
• W2891422085 hasConcept C126322002 @default.
• W2891422085 hasConcept C159047783 @default.
• W2891422085 hasConcept C203014093 @default.
• W2891422085 hasConcept C22070199 @default.
• W2891422085 hasConcept C2522874641 @default.
• W2891422085 hasConcept C2777714996 @default.
• W2891422085 hasConcept C2777863537 @default.

• next